Premium Information is available for this item - Upgrade for $1 a day
6505-00-200-1589
Usp Warfarin Sodium Tablets
6505002001589 002001589 56-011-70
INC: 27974 Warfarin Sodium Tablets
![]()
November 2023
7

Marketplace 6505-00-200-1589
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-200-1589 5+ Documents (More...)
-00-200-1589 Tablets 6505002001589 Usp Warfarin Sodium Tablets 6505002001589 Sodium Tablets 6505002001589
Tablets 6505002001589 https Usp Warfarin Sodium Tablets 6505002001589 enable JavaScript Usp Warfarin
Usp Warfarin Sodium Tablets 6505002001589 Tablets 6505002001589 Sodium Tablets 6505002001589 https
www.nsnlookup.com /fsg-65/fsc-6505/ca 6505-21-846-1989 Usp Warfarin Sodium Tablets 6505218461989 6505002001589
Usp Warfarin Sodium Tablets 6505002001589 6505002001589 Tablets 6505002001589 https https https
fsg-65/fsc-6505/us 6505-00-254-5305 Usp Warfarin Sodium Tablets 6505002545305 6505270057724 us 6505-00-200-1589
Usp Warfarin Sodium Tablets 6505002001589 Usp Warfarin Sodium Tablets 6505009738502 Tablets 6505270057724
6505-00-973-8502 Usp Warfarin https Usp Warfarin Sodium Tablets 6505002001589 Tablets 6505002545305
Usp Warfarin Sodium Tablets 6505002001589 6505-01-052-2857 6505-01-052-2856 6505-27-005-7724 6505
-00-973-8502 6505-00-200-1589 326-1598 6505-00-982-4229 Stock Numbers Related to 6505-00-200-1589 6505
Restrictions 6505-00-200-1589
6505-00-200-1589 is a Usp Warfarin Sodium Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-00-200-1589
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-200-1589
- Part Number
- Manufacturer
- Status
- 56-011-70
- Manufacturer
- 04490 - Bristol-Myers Squibb Pharma Company (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-00-200-1589
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 2.500 Milligrams Warfarin Sodium Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
Similar Supply Items to 6505-00-200-1589


















Freight Information 6505-00-200-1589
6505-00-200-1589 has freight characteristics.. 6505-00-200-1589 has a variance between NMFC and UFC when transported by rail and the description should be consulted.